Investor Relations - Accredo Pharma Science Private Limited

Investor Relations

Your gateway to financial transparency and investment opportunities

Initial Public Offering

Complete information about our upcoming IPO journey

IPO Coming Soon

Be part of Accredo's growth story. Get ready to invest in the future of pharmaceutical innovation.

Get IPO Updates

Prospectus

Coming Soon

Access our Draft Red Herring Prospectus (DRHP) and Red Herring Prospectus (RHP) documents.

Price Band

Coming Soon

IPO price band and subscription details will be announced soon.

IPO FAQs

Available

Frequently asked questions about our IPO process and investment opportunities.

Registrar Details

Available

Information about our registrar and transfer agent for IPO applications.

Financial Information

Comprehensive financial reports and quarterly results

Annual Reports

Available

Download our comprehensive annual reports and audited financial statements.

Quarterly Results

Latest: Q2 FY25

Access our quarterly financial results and earnings presentations.

Shareholding Pattern

Detailed breakdown of our ownership structure

Current Shareholding

Updated: Q2 FY25

Current shareholding pattern and distribution among different categories of shareholders.

Historical Data

Available

Historical shareholding patterns and changes over previous quarters.

Stock Information

Live stock data and trading information (Available after listing)

NSE Trading

Post Listing

Live NSE stock price, trading volume, and market data.

BSE Trading

Post Listing

Live BSE stock price, trading volume, and market performance.

Corporate Announcements

Latest corporate updates and regulatory filings

Latest Announcements

Updated Daily

Corporate announcements, press releases, and material updates.

Regulatory Filings

Available

Regulatory filings with stock exchanges and statutory compliance documents.

Investor Alerts

Subscribe Now

Subscribe to get instant notifications about important corporate updates.

Corporate Calendar

Updated

Important dates for meetings, results, dividends, and other corporate events.